臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"謝明裕"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 36-60 of 120 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
高雄醫學大學	2007	EARLY MORTALITY AND RESPONSES IN NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B-RELATED DECOMPENSATION WITH LAMIVUDINE THERAPY: EVALUATION OF MELD AND INDEX SCORING SYSTEMS AS PROGNOSTIC PREDICTORS	戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍
高雄醫學大學	2007	The presence of Antinuclear Antibody is associated with a negative response to combination therapy with peginterferon and ribavirin for patients without genotype 1 chronic hepatitis C infection	謝明彥;戴嘉言;黃志富;莊萬龍;侯乃仁;李立柏;陳信成;謝明裕;王良彥;張文宇;余明隆
高雄醫學大學	2007	High chance of cure in HCV genotype 1 patients with a low viral load achieving an RVR treated for 24 wks with pegylated interferon alfa-2a (PEGASYS) plus ribavirin (COPEGUS): Prospective, randomized, controlled study comparing 24 & 48 wks of treatm	余明隆;戴嘉言;黃志富;李立柏;謝明彥;丘長富;侯乃仁;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍*
高雄醫學大學	2006	Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.	林子堯;莊萬龍;莊豔凰;余明隆;謝明裕;王良彥;蔡榮發 ; Zu-Yau Lin;Wan-Long Chuang;Yen-Huang Chuang;Ming-Lung Yu;Ming-Yuh Hsieh;Liang-Yen Wang;Jung-Fa Tsai
高雄醫學大學	2006	A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan.	余明隆;戴嘉言;林子堯;李立柏;侯乃仁;謝明彥;陳信成;謝明裕;王良彥;張文宇;莊萬龍 ; Ming-Lung Yu;Chia-Yen Dai;Zu-Yau Lin;Li-Po Lee;Nei-Jen Hou;Ming-Yen Hsieh;Shinn-Cherng Chen;Ming-Yuh Hsieh;Liang-Yen Wang;Wen-Yu Chang;Wan-Long Chuang
高雄醫學大學	2006	A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.	余明隆;林錫銘;李全謨;戴嘉言;張文宇;陳信成;李立柏;林子堯;謝明裕;王良彥;莊萬龍;廖運範 ; Yu ML;Lin SM;Lee CM;Dai CY;Chang WY;Chen SC;Lee LP;Lin ZY;Hsieh MY;Wang LY;Chuang WL;Liaw YF
高雄醫學大學	2006	Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.	余明隆;戴嘉言;李立柏;謝明彥;侯乃仁;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 ; Yu ML;Dai CY;Lee LP;Hsieh MY;Hou NJ;Huang JF;Lin ZY;Chen SC;Hsieh MY;Wang LY;Chang WY;Chuang WL
高雄醫學大學	2006	The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.	黃志富;莊萬龍;戴嘉言;陳信成;林子堯;李立柏;王良彥;謝明裕;張文宇;余明隆 ; Jee-Fu Huang;Wan-Long Chuang;Chia-Yen Dai;Shinn-Cherng Chen;Zu-Yau Lin;Li-Po Lee;Liang-Yen Wang;Ming-Yuh Hsieh;Wen-Yu Chang;Ming-Lung Yu
高雄醫學大學	2006	Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.	戴嘉言;莊萬龍;張文宇;陳信成;李立柏;謝明彥;侯乃仁;林子堯;黃志富;謝明裕;王良彥;余明隆 ; Dai CY;Chuang WL;Chang WY;Chen SC;Lee LP;Hsieh MY;Hou NJ;Lin ZY;Huang JF;Hsieh MY;Wang LY;Yu ML
高雄醫學大學	2006	A randomized study of peginterferon and ribavirin for 16 vs 24 weeks in patients with genotype 2 chronic hepatitis C	余明隆;戴嘉言;黃志富;侯乃仁;李立柏;謝明彥;丘長富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍
高雄醫學大學	2006	Predictors for early mortality in lamivudine-treated patients with chronic hepatitis B-related decompensation in Taiwan ”has been accepted for poster presentation at the forthcoming.	戴嘉言;莊萬龍;李立柏;謝明裕;侯乃仁;陳信成;林子堯;謝明彥;王良彥;黃志富;張文宇;余明隆
高雄醫學大學	2006	Predictors for early mortality in lamivudine-treated patients with chronic hepatitis B-related decompensation in Taiwan ”has been accepted for poster presentation at the forthcoming.	戴嘉言;莊萬龍;李立柏;謝明裕;侯乃仁;陳信成;林子堯;謝明彥;王良彥;黃志富;張文宇;余明隆
高雄醫學大學	2005	Safety of fine-needle aspiration in patients with small hepatocellular carcinoma.	王志文;林子堯;莊萬龍;王良彥;余明隆;陳信成;謝明裕;蔡榮發;張文宇 ; Wang CW;Lin ZY;Chuang WL;Wang LY;Yu ML;Chen SC;Hsieh MY;Tsai JF;Chang WY.
高雄醫學大學	2005	Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma	蔡榮發;鄭貞英;莊麗月;尤慧玲;王良彥;謝明裕;陳信成;莊萬龍;林子堯;余明隆;戴嘉言 ; Tsai JF;Jeng JE;Chuang LY;You HL;Wang LY;Hsieh MY;Chen SC;Chuang WL;Lin ZY;Yu ML;Dai CY
高雄醫學大學	2005	Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin.	戴嘉言;莊萬龍;張文宇;陳信成;李立柏;謝明彥;侯乃仁;林子堯;謝明裕;王良彥;余明隆 ; Dai CY;Chuang WL;Chang WY;Chen SC;Lee LP;Hsieh MY;Hou NJ;Lin ZY;Hsieh MY;Wang LY;Yu ML
高雄醫學大學	2005	Polymorphisms in the interferon-gamma gene at position+874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin	戴嘉言;莊萬龍;張文宇;陳信成;李立柏;謝明彥;侯乃仁;林子堯;謝明裕;王良彥;余明隆 ; Dai CY;Chuang WL;Chang WY;Chen SC;Lee LP;Hsieh MY;Hou NJ;Lin ZY;Hsieh MY;Wang LY;Yu ML
高雄醫學大學	2005	Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.	莊萬龍;戴嘉言;張文宇;李立柏;林子堯;陳信成;謝明裕;王良彥;余明隆 ; Chuang WL;Dai CY;Chang WY;Lee LP;Lin ZY;Chen SC;Hsieh MY;Wang LY;Yu ML
高雄醫學大學	2005	Tumor necrosis factor alpha promoter polymorphism at position-308 predicts hepatitis C virus response to combination therapy with high dose interferon and ribavirin	戴嘉言;余明隆;莊萬龍;李立柏;謝明裕;侯乃仁;張文宇 ; Dai CY;Yu ML;Chuang WL;Lee LP;Hsieh MY;Hou NJ;Chang WY
高雄醫學大學	2005	Interferon-alpha could reduce the occurrence of liver cirrhosis and hepatocellular carcinoma for naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study	莊萬龍;余明隆;戴嘉言;陳信成;李立柏;謝明彥;林子堯;謝明裕;王良彥;蔡榮發;黃志富
高雄醫學大學	2005	A randomized trial of 24-week versus 48-week courses of peginterferon alpha-2b plus ribavirin for genotype-1b infected chronic hepatitis C patients: a pilot study in Taiwan	余明隆;戴嘉言;林子堯;李立柏;謝明彥;陳信成;謝明裕;王良彥;張文宇;莊萬龍
高雄醫學大學	2005	小型肝細胞癌血清第二型類胰島素生長因子之研究	蔡榮發;王良彥;謝明裕;陳信成;莊萬龍;林子堯;余明隆;戴嘉言;謝明彥;李立柏
高雄醫學大學	2005	甲型腫瘤壞死因子促動基因–308基因多型性與高劑量甲型干擾素合併ribavirin治療慢性C型肝炎療效之關聯	戴嘉言;余明隆;.莊萬龍;李立柏;謝明彥;侯乃仁;林子堯;陳信成;謝明裕;王良彥;蔡榮發;王良彥;蔡榮發;張文宇
高雄醫學大學	2005	感染基因型第二型之慢性C型肝炎病患以長效型干擾素合併Rivbavirin治療16及24週療程之比較:期中分析	戴嘉言;余明隆;李立柏;謝明彥;侯乃仁;黃志富;丘長富;林子堯;陳信成;謝明裕;王良彥;莊萬龍;張文宇
高雄醫學大學	2005	Polymorphisms in the Interferon-gamma gene at position +874 in patients with chronic Hepatitis C treated with high dose Interferon-Alpha and Ribavirin	戴嘉言;莊萬龍;張文宇;陳信成;李立柏;謝明彥;侯乃仁;林子堯;謝明裕;王良彥;余明隆
高雄醫學大學	2004	檳榔是肝硬化病人併發肝癌的危險因子	蔡榮發;鄭貞英;莊麗月;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言 ; Tsai JF;Jeng JE;Chuang LY;Ho MS;Ko YC;Lin ZY;Hsieh MY;Chen SC;Chuang WL;Wang LY;Yu ML;Dai CY

Showing items 36-60 of 120 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2823490
	???header.visitor??? : 30346047 ???header.onlineuser??? : 1152 ???header.sponsordeclaration???